TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 830 participants.
Also called NCT03357367
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 830 participants
- Sponsor
- Registry
-
NCT03357367
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT03357367. Allocation not applicable; no masking; primary purpose treatment. Start 2018-02-08 (actual); primary completion 2021-09-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin
- Acronym
- PIRAAT
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- TiVi system
- Lead sponsor
- University Hospital, Angers
Record details
- Record id
cardio:ct-nct03357367- Content hash
9f42790bc3d9f9c240f497e14f03bac29dcec3c6a535d5bcee36447ca90eb8fa